Study: Experimental Alzheimer’s drug may slow progression, but with significant side effects

A new study finds that an experimental Alzheimer’s drug may slow the progression of the disease in its early stages, but it comes with significant side effects. CBS News chief medical correspondent Dr. Jon LaPook joins John Dickerson on “Prime Time” to discuss.